Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
07/06/2011 | EP1492765B1 Novel gamma secretase inhibitors |
07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
07/06/2011 | EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
07/06/2011 | CN102119140A Sphingosine-1-phosphate (S1P) receptor antagonists and methods for use thereof |
07/06/2011 | CN102115787A MicroRNA (Ribose Nucleic Acid) and application of antisensenucleic acid of microRNA to diagnosis, prevention, treatment and/or prognostic evaluation of heart disease |
07/06/2011 | CN102115478A Furo-indole compounds and preparation method and application thereof |
07/06/2011 | CN102115473A Bis-heterocyclic imidazolyl compounds |
07/06/2011 | CN102114245A Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof |
07/06/2011 | CN102114244A Compositions and methods for treating cognitive disorders |
07/06/2011 | CN102114231A Medicine for treating arrhythmia |
07/06/2011 | CN102114214A Chinese medicine for treating diabetic foot |
07/06/2011 | CN102114196A Chinese herbal tea for treating acute viral myocarditis |
07/06/2011 | CN102114183A Medicament for treating hypertension |
07/06/2011 | CN102114178A Traditional Chinese medicine for treating diabetic coronary heart disease |
07/06/2011 | CN102114177A Chinese medicine oral decoction for treating piles |
07/06/2011 | CN102114170A Traditional Chinese medicine composition for preventing and treating myocardial ischemia reperfusion injury and preparation method thereof |
07/06/2011 | CN102114141A Traditional Chinese medicine for treating diabetic cardiopathy |
07/06/2011 | CN102114127A Multifunctional good medicine for heart and preparation method thereof |
07/06/2011 | CN102114126A Traditional Chinese medicine for treating diabetic retinopathy |
07/06/2011 | CN102114121A Traditional Chinese medicine for treating diabetic retinopathy |
07/06/2011 | CN102114104A New application of dittany bark extract in resisting atherosclerosis |
07/06/2011 | CN102114096A Traditional Chinese medicine oral granules for treating cardiovascular and cerebrovascular diseases |
07/06/2011 | CN102114095A Traditional Chinese medicine for treating diabetic eye diseases |
07/06/2011 | CN102114093A Application of Tongxinluo in preparing medicament for treating pulmonary hypertension |
07/06/2011 | CN102114087A Traditional Chinese medicine for treating diabetic coronary heart disease |
07/06/2011 | CN102114085A Traditional Chinese medicine oral decoction for treating coronary heart disease |
07/06/2011 | CN102114073A Traditional Chinese medicine formula for treating apoplectic hemiplegia |
07/06/2011 | CN102114072A Red sage root extract sustained-release micropills and preparation method and application thereof |
07/06/2011 | CN102114017A Medicinal composition containing amlodipine and perindopril and application thereof |
07/06/2011 | CN102114015A Solid oral preparation containing telmisartan and preparation method thereof |
07/06/2011 | CN102114012A Medicinal composition for treating heart cerebrovascular diseases as well as preparation method and application thereof |
07/06/2011 | CN102114005A Tracleer capsule and preparation method thereof |
07/06/2011 | CN102114004A Double-layer sustained-release nifedipine tablet and preparation method thereof |
07/06/2011 | CN102114003A Sustained-release pellet of hydroxysafflor yellow A as well as preparation method and applications thereof |
07/06/2011 | CN102114002A Enhanced immediate release formulations of topiramate |
07/06/2011 | CN102113994A Medicament for treating cerebral blood-vessel dilate and preparation method thereof |
07/06/2011 | CN101897692B Artificial muskiness and isosorbide mononitrate composite orally disintegrating tablet and preparation method thereof |
07/06/2011 | CN101850098B Traditional Chinese medicine composition capable of nourishing blood, tonifying qi, restoring pulse and tranquillizing palpitation and novel application thereof |
07/06/2011 | CN101810620B Methionine-vitamin B1 composite injection and preparation method thereof |
07/06/2011 | CN101797344B Method for preparing refined total flavonoids in herba lophatheri |
07/06/2011 | CN101711850B Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method |
07/06/2011 | CN101711849B Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method |
07/06/2011 | CN101703745B Chinese medicinal composition for treating painful chest and hypochondrium and chest obstruction, and preparation method thereof |
07/06/2011 | CN101653454B Medicament capable of dehydrating and withering pathological tissues |
07/06/2011 | CN101628059B Drug composite and drug preparation containing drug composite |
07/06/2011 | CN101530424B Preparation of palaeo-oceanographical organism medical stone with muscle-penetrating applying treatment for health preservation, rehabilitation and health care |
07/06/2011 | CN101524488B Preparation method of compound bamboo leave flavone dripping pill |
07/06/2011 | CN101461782B Sub-microemulsion preparation for levocarnitine injection and preparation method thereof |
07/06/2011 | CN101198614B Thienopyrimidine derivative |
07/06/2011 | CN101119986B Optically active tetrahydronaphthalene derivative |
07/06/2011 | CN101052397B 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
07/06/2011 | CN101048408B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
07/05/2011 | US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors |
07/05/2011 | US7973160 Nitrogen-containing aromatic derivatives |
07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
07/05/2011 | US7973030 Benzothiazepine and benzothiepine compounds |
07/05/2011 | US7973023 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
07/05/2011 | CA2486728C Novel physiologically active substances useful for suppressing vegf production |
07/05/2011 | CA2483228C Carboxamides |
07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
07/05/2011 | CA2461625C Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary hypertension |
07/05/2011 | CA2459172C Bicyclic compound, production and use thereof |
07/05/2011 | CA2457319C Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
07/05/2011 | CA2446136C Pyruvate derivatives |
07/05/2011 | CA2436462C Inhibitors of cruzipain and other cysteine proteases |
07/05/2011 | CA2423279C Phthalazinone derivatives |
07/05/2011 | CA2390081C Modified viral surface proteins which bind to cells of tumor vasculature |
06/30/2011 | WO2011079273A2 Methods and compositions for cardiovascular diseases and conditions |
06/30/2011 | WO2011079076A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors |
06/30/2011 | WO2011078795A1 Bridged morpholino substituted purines |
06/30/2011 | WO2011078712A1 Combination composition useful for treating cardiovascular diseases |
06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
06/30/2011 | WO2011078370A1 Novel parabanic acid derivative and drug having the same as active ingredient |
06/30/2011 | WO2011078323A1 Active oxygen production inhibitor and anti-hypertensive agent |
06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
06/30/2011 | WO2011078204A1 Prophylactic or therapeutic agent for hyperlipemia, and anti-fatigue agent |
06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
06/30/2011 | WO2011078102A1 Novel phenoxypyrimidine derivative |
06/30/2011 | WO2011077800A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
06/30/2011 | WO2011077712A1 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same |
06/30/2011 | WO2011077711A1 Novel 2-pyridone derivative and pharmaceutical product containing same |
06/30/2011 | WO2011077171A1 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity |
06/30/2011 | WO2011076811A1 Carboxamide compounds and their use as calpain inhibitors |
06/30/2011 | WO2011075775A1 Carrier composition |
06/30/2011 | WO2011027257A3 Pcsk9 vaccine |
06/30/2011 | WO2011016686A3 Prasugrel disulfonate or crystalline forms thereof, method for preparing same, and pharmaceutical composition containing same |
06/30/2011 | US20110160309 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
06/30/2011 | US20110160305 Oral Delivery of Therapeutic Doses of Glutathione |
06/30/2011 | US20110160300 Renin Inhibitors and Methods of Use Thereof |
06/30/2011 | US20110160296 Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine |
06/30/2011 | US20110160294 Compositions and methods for treating ischemia and ischemia-reperfusion injury |
06/30/2011 | US20110160292 Regulation of Integrin Surface Expression |
06/30/2011 | US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
06/30/2011 | US20110160285 Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy |
06/30/2011 | US20110160281 RNA Interference Mediated Inhibition of Vascular Cell Adhesion Molecule (VCAM) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
06/30/2011 | US20110160274 Fenofibrate formulation with enhanced oral bioavailability |